CNBC's Meg Tirrell reports details from Amgen's earnings conference call, including what CEO Robert Bradway has to say. The "Fast Money" traders weigh in on the biotech sector.
Earnings are out for Amgen. CNBC's Meg Tirrell reports the details.
A strategy of making cheap bets on sliding stocks has already returned 30 percent this quarter, according to Goldman’s options research team.
Jefferies shares its favorite biotech stock ideas to pick up amid the recent share price weakness due to Hillary Clinton's rising poll numbers.
Chris Raymond, Raymond James analyst, discusses how to trade the biotech sell-off amid election season.
The "Fast Money" traders share their first moves for the market open.
The "Fast Money" traders share their final trades of the day, including Amgen, Universal Display Corp. and more.
The "Fast Money" traders discuss the trade on biotech stocks, with healthcare being the worst-performing sector today.
U.S. is the best house to invest in a bad neighbhorhood.
Shares of Ligand Pharmaceuticals plunged 12 percent Tuesday after Amgen said its multiple myeloma drug, Kyprolis, did not outperform Takeda Pharmaceutical's Velcade in a late-stage study.
Jim Cramer’s explaining how to level the playing field with the help of Amazon.
The "Fast Money" traders debated whether it's time to pile into the biotech sector after the sector gained 3 percent on Monday.
CNBC contributor Mike Khouw shares his bullish bet on Amgen.
The biotechnology sector made sizeable gains on Monday amid acquisition news.
The "Fast Money" traders give you 5 trades in biotech.
Aside from the financial crisis, health care hasn't lagged the broader market this badly since Bill Clinton was president.
Stocks that would do well in the event of a GOP presidential victory are no longer lagging the Clinton stocks as much as they had been.
With biotechs in the political crosshairs, is now the time to look at the space? With Michael Yee, RBC Capital biotech analyst.
The "Halftime Report" traders give their final trades of the show.
The "FMHR" traders reveal their final trades, including Lending Club and Amgen.